Serum YKL-40 Levels in Patients with Asthma or COPD: A Pilot Study

• Published in: Medicina (Kaunas, Lithuania) Lithuania), 2023-02, Vol.59 (2), p.383
• Main Authors: Popețiu, Romana Olivia, Donath-Miklos, Imola, Borta, Simona Maria, Moldovan, Silviu Daniel, Pilat, Luminița, Nica, Dragoș Vasile, Pușchiță, Maria
• Format: Article
• Language: English
• Subjects: Adult; Airway management; Asthma; Biomarkers; Blood; bronchial asthma; C-Reactive Protein; Chitinase-3-Like Protein 1; Chronic obstructive pulmonary disease; Coronaviruses; COVID-19; Diagnosis; Fibrinogen; Glycoproteins; Health aspects; Hospitals; Humans; Inflammation; Interleukin-6; Lung diseases, Obstructive; Lymphocytes; Measurement; Medical examination; Middle age; Neutrophils; Pilot Projects; Population; Pulmonary Disease, Chronic Obstructive; Respiratory diseases; Sample size; serum YKL-40; Steroids; Variables; White people
• ISSN: 1648-9144; 1010-660X; 1648-9144
• DOI: 10.3390/medicina59020383

Bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) are not only common obstructive respiratory conditions but also major causes of morbidity and mortality worldwide. There is, however, a surprising lack of blood-based biomarkers for separating between these pulmonary disorders. The aim of this study was to assess the practical relevance of using serum YKL-40, single or combined, for this purpose. : Subjects included Romanian patients with BA ( = 24) or COPD ( = 27). YKL-40, fibrinogen, pre-treatment C-reactive protein (CRP), post-treatment CRP, erythrocyte sedimentation rate, interleukin 6 (IL-6), procalcitonin (PCT), absolute neutrophil count, neutrophil percentage, absolute lymphocyte count, lymphocyte percentage, absolute eosinophil count, and eosinophil percentage were measured and compared between these patients. : This is the first study investigating the clinical significance of serum YKL-40 in delineating between COPD and BA in Caucasian populations. Only fibrinogen and YKL-40 levels were different between COPD and BA, with the measured values being significantly elevated. These patients exhibited distinct inflammatory profiles. Using the upper quartiles of these variables for the pooled study population (YKL-40: 5100 pg/mL; fibrinogen: 552 mg/dL) as cut-off values, subjects were classified into high or low groups. High YKL-40 adults revealed significantly increased PCT levels. High fibrinogen subjects, by contrast, showed significantly elevated IL-6 concentrations and pre-treatment CRP levels. Low YKL-40 and fibrinogen patients showed the absence of COPD. Combined use of serum YKL-40 and fibrinogen may be useful for identifying the absence of COPD.